Company: GSRF
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-111032
Chunk: 68

Company: GSR IV Acquisition Corp.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 8
Chunk 68
---
. For information identifying important factors that could cause actual results to differ materially
from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus
for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities
filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.

Overview

We are a blank check company
incorporated on May 10, 2023, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more businesses or entities (“Business Combination”).

As of September 30, 2025,
we had not yet commenced operations. All activity through September 30, 2025 relates to our formation and our Initial Public Offering
which is described below, and since the Initial Public Offering, our search for a Business Combination. We will not generate any operating
revenues until after the completion of our initial Business Combination, at the earliest. We generate non-operating income from the proceeds
held in a trust account (the “Trust Account”) with Odyssey Transfer and Trust Company acting as trustee. We have selected
December 31 as our fiscal year end.

Initial Public Offering and Private Placement

The registration statement
for the Company’s Initial Public Offering was declared effective on September 2, 2025. On September 5, 2025, the
Company consummated the Initial Public Offering of 23,000,000 Units including 3,000,000 additional public units as the underwriters’
over-allotment option was exercised in full, at $10.00 per Unit, generating gross proceeds of $230,000,000.

Simultaneously with the consummation
of the Initial Public Offering and the sale of the Units, the Company consummated the Private Placement of 655,500 units including 45,000
additional Private Placement Units as the underwriters’ over-allotment option was exercised in full to the Sponsor, at a price of
$10.00 per Private Placement Unit, generating total proceeds of $6,555,000. Out of the aggregate amount of $6